Abstract 137: Projected Impact Of Non-pharmacologic Management Of Stage 1 Hypertension Among Lower-risk U.s Adults

Abstract only Introduction: The 2017 ACC/AHA guidelines lowered the diagnostic blood pressure (BP) threshold, resulting in a new hypertension diagnosis for millions of younger, lower-risk U.S adults. Clinicians are encouraged to counsel these patients on health behavior modification. However, the po...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2022-09, Vol.79 (Suppl_1)
Main Authors: Sims, Kendra D, Wei, Pengxiao, Bellows, Brandon K, Penko, Joanne, Hennessy, Susan, Kazi, Dhruv S, Boylan, Ross, Moran, Andrew E, Bibbins-Domingo, Kirsten
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only Introduction: The 2017 ACC/AHA guidelines lowered the diagnostic blood pressure (BP) threshold, resulting in a new hypertension diagnosis for millions of younger, lower-risk U.S adults. Clinicians are encouraged to counsel these patients on health behavior modification. However, the potential population-level benefits from these non-pharmacologic interventions have not been assessed. Methods: We used the Cardiovascular Disease (CVD) Policy Model to simulate CVD events, mortality, and healthcare costs between 2018 and 2027. Simulations targeted US adults aged 35-64 years with untreated systolic BP 130-139 mmHg. Based on 2015-2018 NHANES estimates, we defined individuals as lower-risk based on not having diabetes, chronic kidney disease, or CVD and a predicted
ISSN:0194-911X
1524-4563
DOI:10.1161/hyp.79.suppl_1.137